Toronto Dominion Bank’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $78.9M | Sell |
1,171,697
-1,293,666
| -52% | -$86.2M | 0.09% | 197 |
|
|
2026
Q1 | $155M | Buy |
2,465,363
+2,237,087
| +980% | +$156M | 0.22% | 78 |
|
|
2025
Q4 | $15.2M | Sell |
228,276
-25,213
| -10% | -$1.63M | 0.02% | 527 |
|
|
2025
Q3 | $17.1M | Buy |
253,489
+30,212
| +14% | +$2.39M | 0.03% | 480 |
|
|
2025
Q2 | $19.5M | Buy |
223,277
+32,374
| +17% | +$2.54M | 0.03% | 391 |
|
|
2025
Q1 | $13M | Sell |
190,903
-31,151
| -14% | -$2.54M | 0.03% | 424 |
|
|
2024
Q4 | $17.3M | Buy |
222,054
+17,532
| +9% | +$1.3M | 0.03% | 378 |
|
|
2024
Q3 | $13.7M | Buy |
204,522
+6,227
| +3% | +$511K | 0.02% | 396 |
|
|
2024
Q2 | $22.5M | Buy |
198,295
+80,129
| +68% | +$10.1M | 0.04% | 289 |
|
|
2024
Q1 | $16.4M | Sell |
118,166
-6,136
| -5% | -$771K | 0.03% | 370 |
|
|
2023
Q4 | $15.4M | Sell |
124,302
-32,945
| -21% | -$3.37M | 0.02% | 441 |
|
|
2023
Q3 | $14.7M | Sell |
157,247
-50,927
| -24% | -$5.74M | 0.02% | 412 |
|
|
2023
Q2 | $26.7M | Buy |
208,174
+7,699
| +4% | +$931K | 0.04% | 300 |
|
|
2023
Q1 | $23.3M | Sell |
200,475
-1,625
| -0.8% | -$182K | 0.04% | 294 |
|
|
2022
Q4 | $22.9M | Buy |
202,100
+29,512
| +17% | +$3.24M | 0.03% | 306 |
|
|
2022
Q3 | $13.9M | Sell |
172,588
-14,603
| -8% | -$1.24M | 0.02% | 391 |
|
|
2022
Q2 | $13.9M | Sell |
187,191
-7,137
| -4% | -$651K | 0.03% | 339 |
|
|
2022
Q1 | $24.9M | Sell |
194,328
-34,948
| -15% | -$3.82M | 0.04% | 249 |
|
|
2021
Q4 | $30.8M | Buy |
229,276
+48,376
| +27% | +$6.95M | 0.04% | 250 |
|
|
2021
Q3 | $24.7M | Buy |
180,900
+10,580
| +6% | +$1.33M | 0.04% | 258 |
|
|
2021
Q2 | $18.2M | Sell |
170,320
-18,244
| -10% | -$1.75M | 0.03% | 335 |
|
|
2021
Q1 | $16.9M | Sell |
188,564
-52,056
| -22% | -$4.89M | 0.03% | 310 |
|
|
2020
Q4 | $22.2M | Buy |
240,620
+26,092
| +12% | +$2.33M | 0.04% | 256 |
|
|
2020
Q3 | $22.1M | Sell |
214,528
-28,252
| -12% | -$2.95M | 0.05% | 219 |
|
|
2020
Q2 | $24.6M | Buy |
242,780
+193,380
| +391% | +$17.3M | 0.06% | 217 |
|
|
2020
Q1 | $3.33M | Sell |
49,400
-14,456
| -23% | -$900K | 0.01% | 572 |
|
|
2019
Q4 | $3.49M | Buy |
63,856
+5,324
| +9% | +$253K | 0.01% | 671 |
|
|
2019
Q3 | $2.18M | Buy |
58,532
+3,592
| +7% | +$140K | ﹤0.01% | 795 |
|
|
2019
Q2 | $2.06M | Sell |
54,940
-23,412
| -30% | -$736K | ﹤0.01% | 810 |
|
|
2019
Q1 | $2.33M | Buy |
78,352
+30,752
| +65% | +$1.08M | ﹤0.01% | 809 |
|
|
2018
Q4 | $1.43M | Buy |
47,600
+39,600
| +495% | +$1.26M | ﹤0.01% | 828 |
|
|
2018
Q3 | $286K | Buy |
+8,000
| New | +$248K | ﹤0.01% | 1036 |
|
|
2017
Q4 | – | Sell |
-14,588
| Closed | -$178K | – | 1263 |
|
|
2017
Q3 | $178K | Buy |
14,588
+10,432
| +251% | +$184K | ﹤0.01% | 938 |
|
|
2017
Q2 | $76K | Buy |
4,156
+456
| +12% | +$8.42K | ﹤0.01% | 1001 |
|
|
2017
Q1 | $78K | Buy |
3,700
+792
| +27% | +$15.5K | ﹤0.01% | 984 |
|
|
2016
Q4 | $43K | Buy |
+2,908
| New | +$51.5K | ﹤0.01% | 1033 |
|
Other funds holding DXCM
Toronto Dominion Bank's DXCM Position: Q2 2026 in Review
Toronto Dominion Bank reduced its DexCom (DXCM) stake by 52% in Q2 2026, selling an estimated $86.2M and leaving 1,171,697 shares worth $78.9M. The position accounts for 0.09% of the portfolio, ranked #197.
Toronto Dominion Bank first reported a position in DXCM in Q4 2016 and has held it in 36 quarters since. The position peaked at $155M in Q1 2026. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Toronto Dominion Bank held 1,171,697 shares of DexCom worth $78.9M as of Q2 2026.
- Toronto Dominion Bank sold 1,293,666 DexCom shares in Q2 2026, an estimated $86.2M.
- DexCom made up 0.09% of Toronto Dominion Bank's portfolio in Q2 2026, its #197 holding.
- Toronto Dominion Bank first reported a position in DexCom in Q4 2016 and has held it in 36 quarters since.
- Toronto Dominion Bank's DexCom position peaked at $155M in Q1 2026.
- 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.